Medpace Holdings, Inc. MEDP | NASDAQ
Company Overview:
6.3 Year Performance Metrics:
Unlock All Reports & Research Dividend Stocks like a BOSS!
MEDP Earnings, Revenue, Cash & Debt, Shares Outstaning:
Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:
Ratios, Profit Margins & Return on Capital:
Projected Future Returns & Dividends for MEDP
Based on past 6.3-year performance, here are MEDP growth metrics:
Share price CAGR of +27.82%
Dividend CAGR of +0%
Using MEDP CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:
| MEDP (DRIP) | MEDP - No DRIP | |
|---|---|---|
| Current Price | $302.25 | $302.25 |
| Start Shares | 33.09 | 33.09 |
| Start Value | $10,000 | $10,000 |
| After 10 years: | ||
| Final Share Count | 33.09 | 33.09 |
| Dividends Payment | $0.00 | $0.00 |
| Annual Dividends | $0 | $0 |
| Yield on cost | 0.00% | 0.00% |
| Share Price | $2,751.85 | $302.25 |
| Total Dividends | $0 | $0 |
| Final Value | $91,045 | $10,000 |
NOTE: Above numbers are our estimate based on MEDP's Dividend and Price CAGR over past 6.3 years.
These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.
We cannot guarantee that your actual returns will meet these estimates.
Get the best Dividend Stock Research Tools:
Company Info
Medpace Holdings, Inc. (MEDP) had its IPO on 2016-08-11, and is trader on NASDAQ stock exchange.
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.
MEDP website: https://www.medpace.com
